Glial brain tumors are clinically known as gliomas, and the exact size of a patient’s survival rate is related to the extent of the disease, the patient’s own status, and other factors. In general, the incidence and mortality rate of patients with high grade glioma are high, with a 5-year survival rate of no more than 5%, meaning that less than 5% of patients are still alive after five years of clinical intervention after diagnosis of advanced glioma; the 3-year survival rate of patients with low-grade glioma is about 30%, meaning that about 30% of patients with early or mid-stage glioma are alive after 3 years of clinical intervention. This means that about 30% of patients with early or intermediate glioma survive after 3 years of clinical intervention. In addition, some low-grade gliomas, if benign, have some potential for cure with complete surgical excision. However, regardless of the form of glioma, early and active comprehensive treatment of patients after clear diagnosis can improve the survival rate and prolong the survival period to some extent.1. Low malignancy: If diagnosed as early stage of glioma, usually with low malignancy, glioma resection surgery is recommended, and postoperative combined with radiotherapy, chemotherapy, immunotherapy and other comprehensive therapies for systemic treatment can help control The average survival period is about 14-16 months, but some patients survive for 5-10 years and may get better results with the right treatment plan. . Patients are advised to actively cooperate with professional doctors for targeted treatment, and to develop good dietary habits to ensure that their bodies can tolerate radiotherapy and stay away from factors that can aggravate the disease, such as tobacco, alcohol and ionizing radiation, to help control the disease and improve the quality of survival.